Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2010
10/14/2010WO2010117992A2 Coupled identification and treatment of cancer
10/14/2010WO2010117633A1 Treatment regimen utilizing neratinib for breast cancer
10/14/2010WO2010117071A1 Ubiquitin fusion gene, and dna vaccine using same
10/14/2010WO2010117059A1 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
10/14/2010WO2010117057A1 Method for treatment of blood tumor using anti-tim-3 antibody
10/14/2010WO2010117055A1 Polypeptide having selective inhibitory activity on protein kinase cα or η
10/14/2010WO2010117011A1 ANTI-Siglec-15 ANTIBODY
10/14/2010WO2010116926A1 Tumor-specific promoter and use thereof
10/14/2010WO2010116899A1 Phosphorylation-inhibiting agent or dephosphorylating agent for pten
10/14/2010WO2010116740A1 Pyridine thio derivative, and pharmaceutical composition which contains same and has anti-helicobacter pylori action
10/14/2010WO2010116669A1 Tumor immunity inducer
10/14/2010WO2010116550A1 Method for testing sensitivity of tumor tissue
10/14/2010WO2010116425A1 Inhibitor of premalignant lesion in colon, and prophylactic agent for colorectal cancer
10/14/2010WO2010116302A1 Imidaz0[1,2-a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
10/14/2010WO2010115942A1 Caspasin inhibitor peptides
10/14/2010WO2010115852A1 Curcuminoids in combination docetaxel for the treatment of cancer and tumour metastasis
10/14/2010WO2010115836A1 Substituted piperidines as ccr3 antagonists
10/14/2010WO2010115736A2 Dihydroorotate dehydrogenase inhibitors
10/14/2010WO2010115719A1 Quinoxaline derivatives and their use for treating benign and malignant tumour disorders
10/14/2010WO2010115630A1 Amatoxin-armed target-binding moieties for the treatment of cancer
10/14/2010WO2010115629A2 Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
10/14/2010WO2010115551A1 Bispecific anti-erbb-1/anti-c-met antibodies
10/14/2010WO2010115491A2 Piperidine and piperazine derivatives as autotaxin inhibitors
10/14/2010WO2010115279A1 Kinase inhibitors and method of treating cancer with same
10/14/2010WO2010077693A3 Method for identifying agents for inhibiting cell motility and invasiveness
10/14/2010WO2010075086A3 Pyrrolidinone inhibitors of pde-4
10/14/2010WO2010075072A3 Long circulating nanoparticles for sustained release of therapeutic agents
10/14/2010WO2010075060A3 Methods and compositions for modulating proline levels
10/14/2010WO2010074541A3 Drug delivery carrier using zz domain
10/14/2010WO2010068794A3 Hif inhibitors and use thereof
10/14/2010WO2010068775A3 Alkyne antagonists of lysophosphatidic acid receptors
10/14/2010WO2010068684A3 Methods and compositions for specific modulation of mcl-1
10/14/2010WO2010068037A3 Anti-cancer composition containing 4-hexylresorcinol-1,3-diol as active ingredient
10/14/2010WO2010066684A3 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
10/14/2010WO2010065962A3 Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
10/14/2010WO2010065787A3 Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
10/14/2010WO2010065613A3 Annexina2 as immunological target
10/14/2010WO2010063011A3 Methods for the treatment of infections and tumors
10/14/2010WO2010059253A9 Methods and compositions for localized agent delivery
10/14/2010WO2010045369A3 Fas/fasl or other death receptor targeted methods and compositions for killing tumor cells
10/14/2010WO2010030781A3 Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancer
10/14/2010WO2010020799A3 Compositions for the treatment of neoplastic diseases
10/14/2010WO2009144395A8 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- α] pyridines, and preparation and therapeutic use thereof
10/14/2010WO2009144394A8 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-α]pyridine derivatives, and preparation and therapeutic use thereof
10/14/2010WO2009124013A8 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
10/14/2010WO2009109952A3 Detection and treatment of an invasive cancer phenotype
10/14/2010WO2009017833A8 Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis, and metastasis
10/14/2010US20100262115 Nanoparticles for cancer sonodynamic and photodynamic therapy
10/14/2010US20100261781 Multivalent aptamer complexes
10/14/2010US20100261779 Phosphate-Modified Oligonucleotide Analogs with Enhanced Immunostimulatory Activity
10/14/2010US20100261778 Tumor Suppressor Killin
10/14/2010US20100261776 Bruton's tyrosine kinase as anti-cancer drug target
10/14/2010US20100261772 Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators
10/14/2010US20100261740 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agent
10/14/2010US20100261739 Method of Treating Non-Small Cell Lung Cancer
10/14/2010US20100261738 Novel polymorphs of erlotinib hydrochloride and method of preparation
10/14/2010US20100261726 Treatment of aml
10/14/2010US20100261720 Heterocyclic compound and pharmaceutical composition thereof
10/14/2010US20100261718 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261717 N3 alkylated benzimidazole derivatives as mek inhibitors
10/14/2010US20100261715 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
10/14/2010US20100261712 Hematopoietic neoplasm chemotherapy
10/14/2010US20100261710 HDAC Inhibitors
10/14/2010US20100261709 Pyridazinone derivatives as parp inhibitors
10/14/2010US20100261708 Diazepane Compounds Which Modulate The CB2 Receptor
10/14/2010US20100261706 Substituted tetracyclic 1h-indeno [1,2-b]pyridine-2(5h)-one analogs thereof and uses thereof
10/14/2010US20100261705 Carbostyril compound
10/14/2010US20100261701 8-Substituted isoquinoline derivative and the use thereof
10/14/2010US20100261697 2-(heterocyclylbenzyl)pyridazinone derivatives
10/14/2010US20100261689 Pyrrolo [1,2-c] imidazole derivatives for use in the prophylaxis or treatment of cancer which is refractory to known cancer therapies
10/14/2010US20100261683 Selective Inhibitors for Cyclin-Dependent Kinases
10/14/2010US20100261681 Alpha-chloro and alpha-bromo phosphonate analogs of lysophosphatidic acid and methods of making and using thereof
10/14/2010US20100261679 CSF-1R, Inhibitors, Compositions, and Methods of Use
10/14/2010US20100261672 Pharmaceutical compositions of pyrimidine-2,4,6-triones
10/14/2010US20100261671 Inulin products with improved nutritional properties
10/14/2010US20100261665 Kinase inhibitor compounds
10/14/2010US20100261653 Polypeptide compounds for inhibiting angiogenesis and tumor growth
10/14/2010US20100261641 Spiro-piperidine compounds and medicinal use thereof
10/14/2010US20100261273 Mammalian Receptor Proteins; Related Reagents and Methods
10/14/2010US20100261271 Regulation of endogenous gene expression in cells using zinc finger proteins
10/14/2010US20100260871 Uses of north american ginseng fractions for treating leukemia
10/14/2010US20100260868 Method of treatment using checkpoint kinase 1 inhibitors
10/14/2010US20100260864 Treatment or prevention of cancer and precancerous disorders
10/14/2010US20100260860 Methods for Treating Vasomotor Symptoms in Castrated Prostatic Cancer Patients with Low Dose Cyproterone Acetate
10/14/2010US20100260848 System for controlled release of an active principle and method for preparation
10/14/2010US20100260835 Pharmaceutical composition
10/14/2010US20100260832 Combination therapy for ovarian cancer
10/14/2010US20100260831 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010US20100260830 Liposomal Formulations of Tocopheryl Amides
10/14/2010US20100260827 Methods of diagnosing, preventing and treating cancer metastasis
10/14/2010US20100260825 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
10/14/2010US20100260823 Preparation with marine collagen for protease inhibition
10/14/2010US20100260817 Polyamine Derivatives
10/14/2010US20100260808 Method for Increasing Immunoreactivity
10/14/2010US20100260807 Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens
10/14/2010US20100260806 Nucleic acids
10/14/2010US20100260793 Defensin-antigen fusion proteins
10/14/2010US20100260788 Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligophosphate Moieties
10/14/2010US20100260786 Methods of treating drug-resistant cancers
10/14/2010US20100260785 SARP-1 Fusion Proteins and Uses Thereof
1 ... 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 ... 2211